Metformin Hydrochloride

This page contains recent news articles, when available, and an overview of Metformin Hydrochloride but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

www.PicksThatMove.com: "Picks that move" Alerts, August 10, 2009 ...  -  ‎Aug 10, 2009‎
GLUMETZA(R) (metformin hydrochloride extended release tablets) is approved for use in adults with type 2 diabetes and promoted by Santarus, TMCnet

Depomed to Present at Canaccord Adams' 29th Annual Global Growth ...  -  ‎Aug 11, 2009‎
GLUMETZA ® (metformin hydrochloride extended release tablets) is approved for use in adults with type 2 diabetes and promoted by Santarus, PharmaLive.com (press release)

Depomed Reports Encouraging Results of its Phase I Trial for DM ...  -  ‎Aug 10, 2009‎
GLUMETZA® (metformin hydrochloride extended release tablets) is approved for use in adults with type 2 diabetes and promoted by Santarus, Inc. in the United PipelineReview.com (press release)

Santarus Reports Second Quarter 2009 Financial Results  -  ‎Aug 4, 2009‎
...which is indicated for the treatment of certain upper GI diseases and disorders, and on GLUMETZA ® (metformin hydrochloride extended release tablets), PharmaLive.com (press release)

September 2005 Pharmaceutical Update  -  ‎Jul 5, 2009‎
Glumetza is a once-daily extended-release formulation of metformin hydrochloride. Glumetza may offer potential advantages such as less-frequent dosing and ADVANCE for Physician Assistants

USFDA seizes Sun Pharma arm drugs  -  ‎Jun 26, 2009‎
...to treat heart failure and abnormal heart rhythm as well as withdraw several batches of generic metformin hydrochloride tablets used to treat diabetes. Times of India

Santarus Inc. (SNTS) Announces December 2009 Action Date for ...  -  ‎Jun 24, 2009‎
...which are indicated for the treatment of certain upper GI diseases and disorders, and on GLUMETZA® (metformin hydrochloride extended release tablets), Lifescience-online

Metformin May Have Long-Term Benefits in Patients With Type 2 Diabetes  -  ‎Apr 10, 2009‎
In the outpatient clinics of 3 hospitals, 390 patients treated with insulin were randomly assigned to receive metformin hydrochloride, 850 mg, or placebo (1 Medscape

Depomed Completes Enrollment of Serada’s Full Phase 3 Clinical ...  -  ‎Apr 2, 2009‎
GLUMETZA ® (metformin hydrochloride extended release tablets) is approved for use in adults with type 2 diabetes and promoted by Santarus, Business Wire (press release)

Santarus Announces FDA Acceptance of New Drug Application for ...  -  ‎Apr 6, 2009‎
...which are indicated for the treatment of certain upper GI diseases and disorders, and on GLUMETZA ® (metformin hydrochloride extended release tablets), Business Wire (press release)

Drug recall to have minimal impact on Sun  -  ‎Apr 2, 2009‎
In March 2008, Caraco withdrew its diabetes drug Metformin Hydrochloride for a similar problem of variance in size. Says independent pharma industry analyst Economic Times

Depomed Completes Enrollment of Serada's Full Phase 3 Clinical ...  -  ‎Apr 3, 2009‎
GLUMETZA® (metformin hydrochloride extended release tablets) is approved for use in adults with type 2 diabetes and promoted by Santarus, Inc. in the United PipelineReview.com (press release)

Metformin�?第二型糖尿病患�?�能有長期助益  -  ‎Apr 16, 2009‎
...在三家醫院的門診病患，有390人以胰島素治療，隨機接�?�metformin hydrochloride 850毫克或安慰劑（一天一至三次）；主�?試驗終點�?看追蹤4.3年間微血管�?�大血管罹病率臺灣新浪網

10-K: DEPOMED INC  -  ‎Mar 6, 2009‎
GLUMETZA(R) (metformin hydrochloride extended release tablets) is a once-daily treatment for adults with type 2 diabetes that we commercialize in the United MarketWatch (press release)

Santarus to Present at Cowen & Company 29th Annual Health Care ...  -  ‎Mar 10, 2009‎
...which are indicated for the treatment of certain upper-GI diseases and disorders, and on GLUMETZA(R) (metformin hydrochloride extended release tablets), FOXBusiness

Santarus Reports Fourth Quarter and Full Year 2008 Financial Results  -  ‎Mar 5, 2009‎
Reported $4.7 million in revenue in the fourth quarter of 2008 associated with the promotion of GLUMETZA (metformin hydrochloride extended release tablets) MarketWatch (press release)

Depomed Reports Fourth Quarter and Year-End 2008 Financial Results  -  ‎Mar 5, 2009‎
GLUMETZA ® (metformin hydrochloride extended release tablets) is approved for use in adults with type 2 diabetes and promoted by Santarus, Business Wire (press release)

Depomed Completes Enrollment of Breeze 1 Phase 3 Clinical Trial ...  -  ‎Mar 2, 2009‎
GLUMETZA(R) (metformin hydrochloride extended release tablets) is approved for use in adults with type 2 diabetes and promoted by Santarus, MarketWatch (press release)

StandoutStocks.com: "Stocks that Standout" picks for today are ...  -  ‎Feb 20, 2009‎
GLUMETZA(R) (metformin hydrochloride extended release tablets) is approved for use in adults with type 2 diabetes and promoted by Santarus, Trading Markets (press release)

Depomed Completes Enrollment Of Breeze 1 Phase 3 Clinical Trial ...  -  ‎Mar 4, 2009‎
GLUMETZA® (metformin hydrochloride extended release tablets) is approved for use in adults with type 2 diabetes and promoted by Santarus, Inc. in the United Medical News Today (press release)

Aurobindo Pharma receives five product approvals from USFDA ...  -  ‎Feb 26, 2009‎
These approvals include two Paragraph IV products - Finasteride Tablets USP and Glyburide & Metformin Hydrochloride Tablets. Aurobindo now has a total of 59 Prdomain Business Register (press release)

有专家研究认为肠溶片在胃肠�?�的�?�收�?完全  -  ‎Mar 5, 2009‎
...�?酸二甲�?��?(Metformin hydrochloride,MFH)是�?��?类抗糖尿病�?�，为目�?治疗Ⅱ型糖尿病的首选�?�物。MFH在胃肠�?�的�?�收�?完全，主�?�?�收部�?在�?肠。新华网

Depomed to Present at Upcoming Conferences  -  Feb 3, 2009
GLUMETZA(R) (metformin hydrochloride extended release tablets) is approved for use in adults with type 2 diabetes and promoted by Santarus, MarketWatch (press release)

Merck Announces Fourth-Quarter and Full-Year 2008 Financial Results  -  Feb 3, 2009
JANUMET (sitagliptin/metformin hydrochloride), a single tablet that targets all three key defects of type 2 diabetes, achieved worldwide sales of $120 WELT ONLINE,

Santarus Submits New Drug Application for ZEGERID Tablet Product  -  Jan 30, 2009
...which are indicated for the treatment of certain upper GI diseases and disorders, and on GLUMETZA ® (metformin hydrochloride extended release tablets), WELT ONLINE,

Wanbury's a strong formulations shot  -  Jan 11, 2009
Wanbury is the leader in the market for anti-diabetes drug metformin hydrochloride and has a strong presence in formulations. Daily News & Analysis,

It's a serious health problem for some who require medication  -  Jan 19, 2009
Antimisiaris said the drugs metronidazole, an antibiotic, and metformin hydrochloride, an anti-diabetic drug, come in look-alike red, white and blue bottles The Salinas Californian,

Depomed Announces Management Promotions  -  Jan 9, 2009
GLUMETZA® (metformin hydrochloride extended release tablets) is approved for use in adults with type 2 diabetes and promoted by Santarus, Inc. in the United PR-Inside.com (Pressemitteilung),

Santarus Announces Complete Response Letter from FDA on Schering ...  -  Jan 13, 2009
...which are indicated for the treatment of certain upper GI diseases and disorders, and on GLUMETZA ® (metformin hydrochloride extended release tablets), WELT ONLINE,

Approval of an Additional Indication of Actos in Japan ...  -  Dec 23, 2008
...diet and exercise plus the single agent. 2. Biguanides which are available for sale in Japan today are metformin hydrochloride and buformin hydrochloride. PharmaLive.com (press release),

What's in a medicine name?  -  Dec 6, 2008
Antimisiaris said the drugs metronidazole, an antibiotic, and metformin hydrochloride, an anti-diabetic drug, come in look-alike red, white and blue bottles Detroit Free Press,

Jury indicts resident on cocaine charges  -  Dec 15, 2008
He also was allegedly carrying several pills of the medication metformin hydrochloride without a prescription. The drug is commonly used by diabetics to Today's Sunbeam - NJ.com,

Santarus Announces Strategic Collaboration with Cosmo for US ...  -  Dec 14, 2008
...which are indicated for the treatment of certain upper GI diseases and disorders, and on GLUMETZA ® (metformin hydrochloride extended release tablets), WELT ONLINE,

Depomed, Inc. Announces Conference Call to Discuss Exclusive North ...  -  Nov 21, 2008
GLUMETZA(R) (metformin hydrochloride extended release tablets) is approved for use in adults with type 2 diabetes and promoted by Santarus, MarketWatch

Depomed, Inc. Announces Exclusive North American License Agreement ...  -  Nov 20, 2008
GLUMETZA(R) (metformin hydrochloride extended release tablets) is approved for use in adults with type 2 diabetes and promoted by Santarus, MarketWatch

Diabetes Drug Lowers Risk of Heart Problems  -  Oct 29, 2008
...“Treatment with metformin hydrochloride was associated with a decreased risk of cardiovascular morality [death] compared with any other oral diabetes agent Ivanhoe,

Cardiovascular Outcomes in Trials of Oral Diabetes Medications: A ...  -  Oct 30, 2008
Results: Treatment with metformin hydrochloride was associated with a decreased risk of cardiovascular mortality (pooled OR, 0.74; 95% CI, Cardiosource,

Santarus Prevails on Claims Disputed by Par Pharmaceutical at ...  -  Nov 5, 2008
...which are indicated for the treatment of certain upper GI diseases and disorders, and on GLUMETZA(R) (metformin hydrochloride extended release tablets), MarketWatch

Study Finds No Heart Problems With Diabetes Drugs  -  Oct 28, 2008
...“Treatment with metformin hydrochloride was associated with a decreased risk of cardiovascular morality [death] compared with any other oral diabetes agent Best Syndication,

Santarus to Present at Rodman & Renshaw 10th Annual Healthcare ...  -  Oct 30, 2008
...which are indicated for the treatment of certain upper GI diseases and disorders, and on GLUMETZA(R) (metformin hydrochloride extended release tablets), MarketWatch

Depomed Reports Third Quarter 2008 Financial Results  -  Oct 30, 2008
GLUMETZA(R) (metformin hydrochloride extended release tablets) is approved for use in adults with type 2 diabetes and promoted by Santarus, Trading Markets (press release),

Diabetes Medication May Be Linked To Lower Risk Of Death From ...  -  Nov 2, 2008
..."Treatment with metformin hydrochloride was associated with a decreased risk of cardiovascular morality [death] compared with any other oral diabetes agent Science Daily (press release)

Medical mix-ups  -  Nov 6, 2008
Antimisiaris said the drugs metronidazole, an antibiotic, and metformin hydrochloride, an antidiabetic drug, come in lookalike red, white and blue bottles, Louisville Courier-Journal,

Santarus Reports Third Quarter 2008 Financial Results  -  Nov 3, 2008
Commenced promotion of GLUMETZA (metformin hydrochloride extended release tablets) to targeted primary care physicians and endocrinologists in October 2008. Earthtimes (press release),

Santarus to Hold Third Quarter 2008 Financial Results Conference ...  -  21 Oct 2008
...which are indicated for the treatment of certain upper GI diseases and disorders, and on GLUMETZA ® (metformin hydrochloride extended release tablets), Business Wire (press release),

Depomed Initiates Second Phase 3 Trial in Menopausal Hot Flashes  -  Oct 20, 2008
GLUMETZA(R) (metformin hydrochloride extended release tablets) is approved for use in adults with type 2 diabetes and promoted by Santarus, MarketWatch

Committee for Medicinal Products for Human Uses Summary of ...  -  Sep 25, 2008
Vildagliptin/metformin hydrochloride Novartis combines these two antidiabetic agents with complementary mechanisms of action. PharmaLive.com (press release),

Santarus Commences GLUMETZA Promotion  -  Oct 10, 2008
...a specialty pharmaceutical company, today announced that it has commenced promotion of GLUMETZA(R) (metformin hydrochloride extended release tablets), MarketWatch

EU Advisory Body Recommends Approval Of Merck KGaA's Kuvan  -  Sep 25, 2008
Vildagliptin/metformin hydrochloride Novartis and Zomarist (vildagliptin / metformin hydrochloride), from Novartis Europharm Ltd, for the treatment of type CNNMoney.com

Depomed Announces Presentation of Clinical Data at the North ...  -  Sep 25, 2008
GLUMETZA(R) (metformin hydrochloride extended release tablets) is approved for use in adults with type 2 diabetes and promoted by Santarus, Trading Markets (press release),

RPT/Novartis/Recommandation positive en Europe pour médicaments  -  Sep 25, 2008
En outre, le comité s'est prononcé de manière positive sur les préparations "Vildagliptin/metformin hydrochloride Novartis" et Zomarist Romandie.com,

COMUNICADO: Glucophage(R) Powder for Oral Solution in Sachet ...  -  Sep 10, 2008
Glucophage(R) (metformin hydrochloride) has been approved worldwide as a first line treatment of Type 2 diabetes. It belongs to the biguanide class of Europa Press (Comunicado de prensa),

Marksans Pharma receives Certificate of suitability for Metformin ...  -  Jul 29, 2008
Marksans Pharma Ltd has announced that the Company has received Certificate of suitability for Metformin Hydrochloride drug substance from the European Equity Bulls,

Depomed to Announce Second Quarter 2008 Financial Results on July ...  -  Jul 17, 2008
GLUMETZA(R) (metformin hydrochloride extended release tablets) is approved for use in adults with type 2 diabetes. ProQuin(R) XR (ciprofloxacin MarketWatch

Santarus Reports Second Quarter 2008 Financial Results  -  Aug 4, 2008
Signed an agreement with Depomed, Inc. in July to promote GLUMETZA (metformin hydrochloride extended release tablets) in the US GLUMETZA is a once-daily, Business Wire (press release),

The Michael J. Fox Foundation Awards Depomed a Preclinical ...  -  Jul 23, 2008
Glumetza(R) (metformin hydrochloride extended release tablets) is approved for use in adults with type 2 diabetes and promoted by Santarus in the United FOXBusiness

Santarus and Depomed Announce US Promotion Agreement for GLUMETZA ...  -  Jul 22, 2008
GLUMETZA (metformin hydrochloride extended release tablets) is indicated as an adjunct to diet and exercise to improve glycemic control in adult patients istockAnalyst.com,

Marksans Pharma gets nod for Metformin HCL; Stock up 4%  -  Jul 29, 2008
Mumbai-headquartered Marksans Pharma Limited has informed that it has received Certificate of suitability for Metformin Hydrochloride drug substance from TopNews,

Depomed's ProQuin(R) XR Achieves First Marketing Authorization in ...  -  Jul 23, 2008
Glumetza(R) (metformin hydrochloride extended release tablets) is approved for use in adults with type 2 diabetes and promoted by Santarus in the United Trading Markets (press release),

Depomed Secures $15 Million in Non-Dilutive Funding for Hot Flash ...  -  Jun 30, 2008
Glumetza(R) (metformin hydrochloride extended release tablets) is approved for use in adults with type 2 diabetes. Proquin(R) XR (ciprofloxacin FOXBusiness

Glenmark Generics receives ANDA approvals  -  Jun 23, 2008
Metformin hydrochloride tablets as monotherapy are indicated as an adjunct to diet and exercise to improve glycemic control in patients with type II Express Pharma,

Depomed Announces Allowance of Additional US Patent Covering ...  -  Jun 17, 2008
Glumetza® (metformin hydrochloride extended release tablets) is approved for use in adults with type 2 diabetes. Proquin® XR (ciprofloxacin hydrochloride) Business Wire (press release),

Glenmark Pharma receives USFDA approval for Trandolapril tablets  -  Jun 20, 2008
Recently, Glenmark Generics received ANDA approvals for Mometasone Furoate ointment USP, 0.1%, Mometasone Furoate cream and Metformin Hydrochloride tablets. Myiris.com,

:

Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on health.mongabay.com/health lead to other sites. health.mongabay.com/health does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is health.mongabay.com/health responsible for dead or misdirected links.

IF YOU NEED A LINK/TEXT REMOVED FROM THIS PAGE, PLEASE CONTACT: mongabay (at) gmail.com